HbA1c Testing Device Market By Type of Device (Laboratory-based Testing Devices, Point-of-care Testing Devices) , By Technology (Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Oth
Description
HbA1c Testing Device Market By Type of Device (Laboratory-based Testing Devices, Point-of-care Testing Devices) , By Technology (Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Others) By End User (Hospitals and Clinics, Diagnostic Laboratories, Homecare Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The HbA1c testing device market was valued at $2.1 billion in 2023, and is projected to reach $3.9 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.
An HbA1c testing device is a medical instrument used to measure glycated hemoglobin (HbA1c) levels in the blood, providing a key indicator of long-term blood glucose control. The test reflects the average blood sugar levels over the past two to three months, making it an essential tool in the management and diagnosis of diabetes. Portable HbA1c testing devices are increasingly popular for point-of-care use, allowing healthcare providers and patients to monitor diabetes more effectively and conveniently.
The growth of the global HbA1c testing device market is majorly driven by alarming increase in the prevalence of diabetes. As per a study published by IDF Diabetes Atlas 10th edition 2021, 537 million individuals were diabetic. This number is estimated to increase to 643 million by 2030 and 783 million by 2045. This highlights the growing demand for diagnostic devices like HbA1c testing to monitor and manage diabetes effectively. In addition, increase in public and healthcare professional awareness of the importance of monitoring long-term blood glucose levels is boosting the adoption of HbA1c tests. Furthermore, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that as the age is the major risk factor for type 2 diabetes. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, rise in focus on individualized treatment plans, particularly for chronic conditions like diabetes, is fostering the demand for regular HbA1c monitoring. However, high cost of devices and testing restrains the market growth. In addition, availability of alternative methods for monitoring diabetes, such as continuous glucose monitoring systems, are becoming increasingly popular due to their real-time glucose tracking abilities, which may reduce demand for HbA1c devices, thus hampering the market growth. On the contrary, improvements in device accuracy, usability, and connectivity, for instance, integration with digital health platforms, are enhancing the appeal of HbA1c testing devices. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The global HbA1c testing device market is segmented into type of device, end user, and region. On the basis of type of device, the market is bifurcated into laboratory-based testing devices and point-of-care (POC) testing devices. As per technology, it is segregated into immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. Depending on end user, it is fragmented into hospitals & clinics, diagnostic laboratories, and homecare settings. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type of device, the point-of-care testing devices segment is expected to dominate the market from 2024 to 2033.
As per technology, the immunoassays segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, the hospitals segment is projected to lead the market in the coming years.
Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global HbA1c testing device market include Abbott Laboratories, Siemens Healthineers AG, Roche Diagnostics, Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company (BD), Thermo Fisher, Mylan N.V, Sysmex Corporation, Menarini Diagnostics, and Bio-Rad Laboratories. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Type Of Device
Laboratory-based Testing Devices
Point-of-care Testing Devices
By Technology
Immunoassays
Chromatography
Enzymatic Assays
Boronate Affinity Chromatography
High-Performance Liquid Chromatography
Others
By End User
Hospitals and Clinics
Diagnostic Laboratories
Homecare Settings
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Abbott Laboratories
Siemens Healthineers AG
Roche Diagnostics
Danaher Corporation (Beckman Coulter)
Becton, Dickinson and Company (BD)
Thermo Fisher
Mylan N.V
Sysmex Corporation
Menarini Diagnostics
Bio-Rad Laboratories
Table of Contents
260 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type Of Device
- 4.2. Laboratory-based Testing Devices
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Point-of-care Testing Devices
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
- 5.2. Immunoassays
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Chromatography
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Enzymatic Assays
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Boronate Affinity Chromatography
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. High-Performance Liquid Chromatography
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- 5.7. Others
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
- CHAPTER 6: HBA1C TESTING DEVICE MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals And Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Diagnostic Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Homecare Settings
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: HBA1C TESTING DEVICE MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type Of Device
- 7.2.3. Market Size and Forecast, By Technology
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. HbA1c Testing Device Market
- 7.2.6.1. Market Size and Forecast, By Type Of Device
- 7.2.6.2. Market Size and Forecast, By Technology
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada HbA1c Testing Device Market
- 7.2.7.1. Market Size and Forecast, By Type Of Device
- 7.2.7.2. Market Size and Forecast, By Technology
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico HbA1c Testing Device Market
- 7.2.8.1. Market Size and Forecast, By Type Of Device
- 7.2.8.2. Market Size and Forecast, By Technology
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type Of Device
- 7.3.3. Market Size and Forecast, By Technology
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France HbA1c Testing Device Market
- 7.3.6.1. Market Size and Forecast, By Type Of Device
- 7.3.6.2. Market Size and Forecast, By Technology
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany HbA1c Testing Device Market
- 7.3.7.1. Market Size and Forecast, By Type Of Device
- 7.3.7.2. Market Size and Forecast, By Technology
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy HbA1c Testing Device Market
- 7.3.8.1. Market Size and Forecast, By Type Of Device
- 7.3.8.2. Market Size and Forecast, By Technology
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain HbA1c Testing Device Market
- 7.3.9.1. Market Size and Forecast, By Type Of Device
- 7.3.9.2. Market Size and Forecast, By Technology
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK HbA1c Testing Device Market
- 7.3.10.1. Market Size and Forecast, By Type Of Device
- 7.3.10.2. Market Size and Forecast, By Technology
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe HbA1c Testing Device Market
- 7.3.11.1. Market Size and Forecast, By Type Of Device
- 7.3.11.2. Market Size and Forecast, By Technology
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type Of Device
- 7.4.3. Market Size and Forecast, By Technology
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China HbA1c Testing Device Market
- 7.4.6.1. Market Size and Forecast, By Type Of Device
- 7.4.6.2. Market Size and Forecast, By Technology
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan HbA1c Testing Device Market
- 7.4.7.1. Market Size and Forecast, By Type Of Device
- 7.4.7.2. Market Size and Forecast, By Technology
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India HbA1c Testing Device Market
- 7.4.8.1. Market Size and Forecast, By Type Of Device
- 7.4.8.2. Market Size and Forecast, By Technology
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea HbA1c Testing Device Market
- 7.4.9.1. Market Size and Forecast, By Type Of Device
- 7.4.9.2. Market Size and Forecast, By Technology
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia HbA1c Testing Device Market
- 7.4.10.1. Market Size and Forecast, By Type Of Device
- 7.4.10.2. Market Size and Forecast, By Technology
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific HbA1c Testing Device Market
- 7.4.11.1. Market Size and Forecast, By Type Of Device
- 7.4.11.2. Market Size and Forecast, By Technology
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type Of Device
- 7.5.3. Market Size and Forecast, By Technology
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil HbA1c Testing Device Market
- 7.5.6.1. Market Size and Forecast, By Type Of Device
- 7.5.6.2. Market Size and Forecast, By Technology
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa HbA1c Testing Device Market
- 7.5.7.1. Market Size and Forecast, By Type Of Device
- 7.5.7.2. Market Size and Forecast, By Technology
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia HbA1c Testing Device Market
- 7.5.8.1. Market Size and Forecast, By Type Of Device
- 7.5.8.2. Market Size and Forecast, By Technology
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA HbA1c Testing Device Market
- 7.5.9.1. Market Size and Forecast, By Type Of Device
- 7.5.9.2. Market Size and Forecast, By Technology
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Siemens Healthineers AG
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Roche Diagnostics
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Danaher Corporation (Beckman Coulter)
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Becton, Dickinson And Company (BD)
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Thermo Fisher
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Mylan N.V
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Sysmex Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Menarini Diagnostics
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Bio-Rad Laboratories
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 2. HBA1C TESTING DEVICE MARKET FOR LABORATORY-BASED TESTING DEVICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. HBA1C TESTING DEVICE MARKET FOR POINT-OF-CARE TESTING DEVICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 5. HBA1C TESTING DEVICE MARKET FOR IMMUNOASSAYS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. HBA1C TESTING DEVICE MARKET FOR CHROMATOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. HBA1C TESTING DEVICE MARKET FOR ENZYMATIC ASSAYS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. HBA1C TESTING DEVICE MARKET FOR BORONATE AFFINITY CHROMATOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. HBA1C TESTING DEVICE MARKET FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. HBA1C TESTING DEVICE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. GLOBAL HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 12. HBA1C TESTING DEVICE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. HBA1C TESTING DEVICE MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. HBA1C TESTING DEVICE MARKET FOR HOMECARE SETTINGS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. HBA1C TESTING DEVICE MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA HBA1C TESTING DEVICE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 22. U.S. HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 25. CANADA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 28. MEXICO HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE HBA1C TESTING DEVICE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 35. FRANCE HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 38. GERMANY HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 41. ITALY HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 44. SPAIN HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. UK HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 46. UK HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 47. UK HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF EUROPE HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 57. CHINA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 60. JAPAN HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 63. INDIA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 66. SOUTH KOREA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 69. AUSTRALIA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 72. REST OF ASIA-PACIFIC HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA HBA1C TESTING DEVICE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 79. BRAZIL HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 82. SOUTH AFRICA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 85. SAUDI ARABIA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA HBA1C TESTING DEVICE MARKET, BY TYPE OF DEVICE, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA HBA1C TESTING DEVICE MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA HBA1C TESTING DEVICE MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 90. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 91. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 92. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 93. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 94. SIEMENS HEALTHINEERS AG: KEY EXECUTIVES
- TABLE 95. SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
- TABLE 96. SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
- TABLE 97. SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
- TABLE 98. SIEMENS HEALTHINEERS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 99. ROCHE DIAGNOSTICS: KEY EXECUTIVES
- TABLE 100. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 101. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 102. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 103. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 104. DANAHER CORPORATION (BECKMAN COULTER) : KEY EXECUTIVES
- TABLE 105. DANAHER CORPORATION (BECKMAN COULTER) : COMPANY SNAPSHOT
- TABLE 106. DANAHER CORPORATION (BECKMAN COULTER) : OPERATING SEGMENTS
- TABLE 107. DANAHER CORPORATION (BECKMAN COULTER) : PRODUCT PORTFOLIO
- TABLE 108. DANAHER CORPORATION (BECKMAN COULTER) : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 109. BECTON, DICKINSON AND COMPANY (BD) : KEY EXECUTIVES
- TABLE 110. BECTON, DICKINSON AND COMPANY (BD) : COMPANY SNAPSHOT
- TABLE 111. BECTON, DICKINSON AND COMPANY (BD) : OPERATING SEGMENTS
- TABLE 112. BECTON, DICKINSON AND COMPANY (BD) : PRODUCT PORTFOLIO
- TABLE 113. BECTON, DICKINSON AND COMPANY (BD) : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 114. THERMO FISHER: KEY EXECUTIVES
- TABLE 115. THERMO FISHER: COMPANY SNAPSHOT
- TABLE 116. THERMO FISHER: OPERATING SEGMENTS
- TABLE 117. THERMO FISHER: PRODUCT PORTFOLIO
- TABLE 118. THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119. MYLAN N.V: KEY EXECUTIVES
- TABLE 120. MYLAN N.V: COMPANY SNAPSHOT
- TABLE 121. MYLAN N.V: OPERATING SEGMENTS
- TABLE 122. MYLAN N.V: PRODUCT PORTFOLIO
- TABLE 123. MYLAN N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 124. SYSMEX CORPORATION: KEY EXECUTIVES
- TABLE 125. SYSMEX CORPORATION: COMPANY SNAPSHOT
- TABLE 126. SYSMEX CORPORATION: OPERATING SEGMENTS
- TABLE 127. SYSMEX CORPORATION: PRODUCT PORTFOLIO
- TABLE 128. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129. MENARINI DIAGNOSTICS: KEY EXECUTIVES
- TABLE 130. MENARINI DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 131. MENARINI DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 132. MENARINI DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 133. MENARINI DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134. BIO-RAD LABORATORIES: KEY EXECUTIVES
- TABLE 135. BIO-RAD LABORATORIES: COMPANY SNAPSHOT
- TABLE 136. BIO-RAD LABORATORIES: OPERATING SEGMENTS
- TABLE 137. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 138. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL HBA1C TESTING DEVICE MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF HBA1C TESTING DEVICE MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN HBA1C TESTING DEVICE MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHBA1C TESTING DEVICE MARKET
- FIGURE 10. GLOBAL HBA1C TESTING DEVICE MARKET SEGMENTATION, BY TYPE OF DEVICE
- FIGURE 11. HBA1C TESTING DEVICE MARKET FOR LABORATORY-BASED TESTING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. HBA1C TESTING DEVICE MARKET FOR POINT-OF-CARE TESTING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL HBA1C TESTING DEVICE MARKET SEGMENTATION, BY TECHNOLOGY
- FIGURE 14. HBA1C TESTING DEVICE MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. HBA1C TESTING DEVICE MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. HBA1C TESTING DEVICE MARKET FOR ENZYMATIC ASSAYS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. HBA1C TESTING DEVICE MARKET FOR BORONATE AFFINITY CHROMATOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. HBA1C TESTING DEVICE MARKET FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. HBA1C TESTING DEVICE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. GLOBAL HBA1C TESTING DEVICE MARKET SEGMENTATION, BY END USER
- FIGURE 21. HBA1C TESTING DEVICE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. HBA1C TESTING DEVICE MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. HBA1C TESTING DEVICE MARKET FOR HOMECARE SETTINGS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 28. COMPETITIVE DASHBOARD
- FIGURE 29. COMPETITIVE HEATMAP: HBA1C TESTING DEVICE MARKET
- FIGURE 30. TOP PLAYER POSITIONING, 2023
- FIGURE 31. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. SIEMENS HEALTHINEERS AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. ROCHE DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. DANAHER CORPORATION (BECKMAN COULTER) : NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. DANAHER CORPORATION (BECKMAN COULTER) : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. DANAHER CORPORATION (BECKMAN COULTER) : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. BECTON, DICKINSON AND COMPANY (BD) : NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. BECTON, DICKINSON AND COMPANY (BD) : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. BECTON, DICKINSON AND COMPANY (BD) : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. THERMO FISHER: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. THERMO FISHER: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. MYLAN N.V: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. MYLAN N.V: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. MYLAN N.V: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. SYSMEX CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. MENARINI DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. MENARINI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. MENARINI DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. BIO-RAD LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
